Top Abstract Purchase Related
Home
>
Node
>
Subnode

Transmission of zearalenone and its metabolite into ruminant milk

Hagler, W.M.; Dankó, G.; Horváth, L.; Palyusik, M.; Mirocha, C.J.

Acta Veterinaria Academiae Scientiarum Hungaricae 28(2): 209-216

1980

ISSN/ISBN: 0001-7205
PMID: 6453515
Document Number: 154803
Crystalline zearalenone revealed traces of zearalenone and .beta.-zearalenol in some extracts of cow milk. Zearalenone and .beta.-zearalenol were present in some sheep milk extracts at 0.001-0.002 ppm. Extracts of urine from the ewe also contained these compounds at levels 0.020-0.050 ppm also discernable with TLC within 24 h of administration of zearalenone. The female lamb with the ewe consumed all milk not used for extraction and exhibited the major sign of hyperestrogenism, an abnormally enlarged vulva, about 10 days after zearalenone had been administered to the ewe. Analytical reverse-phase HPLC is a very sensitive analytical technique for the analysis of these metabolites.

Document emailed within 1 workday
Secure & encrypted payments

Dinleyici, M.; Aydemir, O.; Yildirim, G.K.; Kaya, T.B.; Carman, K.B. 2018: Human mature milk zearalenone and deoxynivalenol levels in Turkey Neuro Endocrinology Letters 39(4): 325-330
Hamprecht, K.; Witzel, S.; Maschmann, J.; Speer, C.P.; Jahn, G. 2000: Transmission of cytomegalovirus infection through breast milk in term and preterm infants. The role of cell free milk whey and milk cells Advances in Experimental Medicine and Biology 478: 231-239
Jenss, H.; Weber, P.; Hartmann, F. 1990: 5-Aminosalicylic acid and its metabolite in breast milk during lactation American Journal of Gastroenterology 85(3): 331
Sehgal, S. 1992: HIV-1 transmission through breast milk: a case report Virus Information Exchange Newsletter for South-East Asia and the Western Pacific 9(2): 56-57
Waweru, C. 2008: Antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission New England Journal of Medicine 359(17): 1845-1846; Author Reply 1846-1847
Mills, J. 2008: Antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission New England Journal of Medicine 359(17): 1846; Author Reply 1846-1847
Kirik, D.L.; Shablovskaia, E.A.; Pinchuk, I.V.; Kikot', V.I.; Krolevetskaia, N.M. 1997: The role of the "milk" factor in the transmission of Campylobacter infection Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 3: 30-33
Coovadia, H.M.; Coutsoudis, A.; Rollins, N.C. 2008: Antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission New England Journal of Medicine 359(17): 1846; Author Reply 1848
Anonymous 1942: Report on market-milk supplies of Standard Milk Ordinance communities. Compliance of the market-milk supplies of certain Standard Milk Ordinance communities with the Grade A pasteurized and Grade A raw milk requirements of the Public Health Service Milk Ordinance and Code, as shown by compliance ratings of 90 percent or more reported by the State Milk-Sanitation authorities during the period January 1, 1940, to December 31, 1941 Public Health Reports 57(7): 228-233
Kumwenda, N.I.; Hoover, D.R.; Mofenson, L.M.; Thigpen, M.C.; Kafulafula, G.; Li, Q.; Mipando, L.; Nkanaunena, K.; Mebrahtu, T.; Bulterys, M.; Fowler, M.Glenn.; Taha, T.E. 2008: Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission New England Journal of Medicine 359(2): 119-129
Kuznetsov, V.G.; Bagriantsev, V.N. 1992: Pasteurized milk as a factor in the transmission of the causative agents of yersiniosis Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 4: 22-26
Ding, J-Jie.; Jiao, Z.; Yu, Y-Qiu.; Shi, X-Jin. 2007: Development and identifiability analysis of parent-metabolite pharmacokinetic model for risperidone and its main active metabolite 9-hydroxyrisperidone Yao Xue Xue Bao 42(6): 631-638
Chan, C.S.; Kim, H.-Y.; Autran, C.; Kim, J.H.; Sinkala, M.; Kankasa, C.; Mwiya, M.; Thea, D.M.; Aldrovandi, G.M.; Kuhn, L.; Bode, L. 2013: Human milk galectin-3 binding protein and breast-feeding-associated HIV transmission Pediatric Infectious Disease Journal 32(12): E473-E475
Arsenault, J.E.; Webb, A.L.; Koulinska, I.N.; Aboud, S.; Fawzi, W.W.; Villamor, E. 2010: Association between breast milk erythropoietin and reduced risk of mother-to-child transmission of HIV Journal of Infectious Diseases 202(3): 370-373
Lohman-Payne, B.; Slyker, J.A.; Moore, S.; Maleche-Obimbo, E.; Wamalwa, D.C.; Richardson, B.A.; Rowland-Jones, S.; Mbori-Ngacha, D.; Farquhar, C.; Overbaugh, J.; John-Stewart, G. 2012: Breast milk cellular HIV-specific interferon γ responses are associated with protection from peripartum HIV transmission Aids 26(16): 2007-2016
John-Stewart, G.C. 2009: Strategic approaches to decrease breast milk transmission of HIV-1: the importance of small things Journal of Infectious Diseases 200(10): 1487-1489
Sixl, W.; Stünzner, D.; Withalm, H.; Köck, M. 1989: Rare transmission mode of FSME (tick-borne encephalitis) by goat's milk Geographia Medica. Suppl 2: 11-14
Savilahti, E.; Tainio, V.M.; Salmenperä, L.; Arjomaa, P.; Kallio, M.; Perheentupa, J.; Siimes, M.A. 1991: Levels of IgA and cow milk antibodies in breast milk vs. the development of atopy in children. Low colostral IgA associated with cow milk allergy Advances in Experimental Medicine and Biology 310: 417-425
Suthutvoravut, U.; Tontisirin, K.; Varavithya, W.; Valyasevi, A.; Björck, I.; Dahlqvist, A. 1984: Wheat extract and milk mixture as a milk substitute for children with milk intolerance Journal of Diarrhoeal Diseases Research 2(3): 168-172
Guay, L.A.; Hom, D.L.; Mmiro, F.; Piwowar, E.M.; Kabengera, S.; Parsons, J.; Ndugwa, C.; Marum, L.; Olness, K.; Kataaha, P.; Jackson, J.B. 1996: Detection of human immunodeficiency virus type 1 (HIV-1) DNA and p24 antigen in breast milk of HIV-1-infected Ugandan women and vertical transmission Pediatrics 98(3 Pt 1): 438-444